Sakar Healthcare Limited - Asset Resilience Ratio

Latest as of September 2025: 0.05%

Sakar Healthcare Limited (SAKAR) has an Asset Resilience Ratio of 0.05% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read SAKAR current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Rs2.16 Million

≈ $23.36K USD Cash + Short-term Investments

Total Assets

Rs4.49 Billion

≈ $48.51 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Sakar Healthcare Limited's Asset Resilience Ratio has changed over time. See SAKAR net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Sakar Healthcare Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SAKAR market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs83.00K	0.0%
Short-term Investments	Rs2.08 Million	0.05%
Total Liquid Assets	Rs2.16 Million	0.05%

Asset Resilience Insights

Limited Liquidity: Sakar Healthcare Limited maintains only 0.05% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Sakar Healthcare Limited Industry Peers by Asset Resilience Ratio

Compare Sakar Healthcare Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Daihan Pharmaceutical Co.Ltd KQ:023910	Drug Manufacturers - Specialty & Generic	11.95%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	16.92%
China Resources Sanjiu Medical & Pharmaceutical Co Ltd SHE:000999	Drug Manufacturers - Specialty & Generic	5.22%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	2.69%
Zhejiang Xianju Pharmaceutical Co Ltd SHE:002332	Drug Manufacturers - Specialty & Generic	6.02%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Hainan Honz Pharmaceutical Co SHE:300086	Drug Manufacturers - Specialty & Generic	0.27%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%

Annual Asset Resilience Ratio for Sakar Healthcare Limited (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Sakar Healthcare Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.07%	Rs3.09 Million ≈ $33.45K	Rs4.15 Billion ≈ $44.91 Million	+0.02pp
2024-03-31	0.05%	Rs2.08 Million ≈ $22.45K	Rs3.89 Billion ≈ $42.03 Million	-0.99pp
2023-03-31	1.05%	Rs35.23 Million ≈ $380.96K	Rs3.36 Billion ≈ $36.37 Million	-1.61pp
2022-03-31	2.65%	Rs71.06 Million ≈ $768.50K	Rs2.68 Billion ≈ $28.96 Million	-1.39pp
2021-03-31	4.04%	Rs71.88 Million ≈ $777.41K	Rs1.78 Billion ≈ $19.23 Million	+3.00pp
2020-03-31	1.04%	Rs12.01 Million ≈ $129.88K	Rs1.15 Billion ≈ $12.45 Million	+0.67pp
2019-03-31	0.37%	Rs3.67 Million ≈ $39.67K	Rs986.85 Million ≈ $10.67 Million	-0.08pp
2018-03-31	0.45%	Rs3.62 Million ≈ $39.18K	Rs811.00 Million ≈ $8.77 Million	-0.19pp
2017-03-31	0.64%	Rs4.52 Million ≈ $48.87K	Rs705.87 Million ≈ $7.63 Million	--

pp = percentage points

About Sakar Healthcare Limited

NSE:SAKAR India Drug Manufacturers - Specialty & Generic

Market Cap

$149.09 Million

Rs13.79 Billion INR

Market Cap Rank

#17666 Global

#917 in India

Share Price

Rs628.05

Change (1 day)

+0.38%

52-Week Range

Rs269.05 - Rs652.10

All Time High

Rs652.10